PubRank

Taichi Shuto

Author PubWeight™ 46.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors. J Am Coll Surg 2002 2.00
2 Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004 1.48
3 Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 2003 1.36
4 Surgical management of cystic hepatic neoplasms. J Gastroenterol 2003 1.08
5 Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: Immunohistochemical evidence. Hepatol Res 2005 1.07
6 Eosinophilic enteritis presenting as acute intestinal obstruction: a case report and review of the literature. Dig Surg 2003 1.05
7 Asymptomatic thrombosis as a late complication of a retrohepatic vena caval graft performed for primary leiomyosarcoma of the inferior vena cava: report of a case. Surg Today 2002 1.04
8 Risk factors for postoperative delirium after liver resection for hepatocellular carcinoma. World J Surg 2004 1.04
9 CD44 and VEGF expression in extrahepatic metastasis of human hepatocellular carcinoma. Hepatogastroenterology 2004 0.95
10 Self-expanding metallic stent for benign biliary strictures: seven-year follow-up. Hepatogastroenterology 2004 0.94
11 Evaluation of the effect of portal vein embolization on liver function by (99m)tc-galactosyl human serum albumin scintigraphy. J Surg Res 2002 0.93
12 Surgical strategy for hepatocellular carcinoma originating in the caudate lobe. Surgery 2004 0.93
13 Correlation between low platelet count and multicentricity of hepatocellular carcinoma in patients with chronic hepatitis C. Hepatol Res 2004 0.92
14 Pseudotumor of the omentum with a fishbone nucleus. J Gastroenterol Hepatol 2007 0.91
15 A simple, noninvasively determined index predicting hepatic failure following liver resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2008 0.90
16 Percutaneous transhepatic metallic stent placement for malignant portal vein stenosis. Hepatogastroenterology 2003 0.90
17 Secondary hemocholecyst after radiofrequency ablation therapy for hepatocellular carcinoma. J Gastroenterol 2003 0.88
18 Risk factors for massive blood loss during liver resection for hepatocellular carcinoma in patients with cirrhosis. Hepatogastroenterology 2007 0.85
19 Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002 0.84
20 Hepatocellular carcinoma arising from nonalcoholic steatohepatitis: report of two cases. Surg Today 2006 0.84
21 Clinicopathologic characteristics of hepatitis C virus-associated intrahepatic cholangiocarcinoma. Dig Surg 2006 0.84
22 Surgical repair of a liver injury in a patient: accompanied with tricuspid regurgitation. Hepatogastroenterology 2003 0.84
23 Multicentric occurrence of hepatocellular carcinoma in patients with a somatic mutation of mitochondorial DNA and hepatitis C virus. Hepatol Res 2003 0.84
24 Hepatectomy with transcatheter arterial embolization for large hepatoma in the caudate lobe. Hepatogastroenterology 2003 0.83
25 Surgery for segmental primary sclerosing cholangitis. Hepatogastroenterology 2004 0.83
26 Treatment with STI571, a tyrosine kinase inhibitor, for gastrointestinal stromal tumor with peritoneal dissemination and multiple liver metastases. J Gastroenterol 2003 0.83
27 Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2002 0.82
28 The separate-lesion type combined hepatocellular carcinoma and cholangiocarcinoma. Hepatogastroenterology 2002 0.82
29 Limy bile: a case of obstructive jaundice and review of 26 cases. Osaka City Med J 2003 0.82
30 Nonoprerative management of obstructive jaundice caused by a benign hepatic cyst. Osaka City Med J 2004 0.81
31 Usefulness of viral concentration measurement by transcription-mediated amplification and hybridization protection as a prognostic factor for recurrence after resection of hepatitis B virus-related hepatocellular carcinoma. Hepatol Res 2003 0.81
32 Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus. World J Surg 2003 0.80
33 Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver. Hepatogastroenterology 2004 0.80
34 Effect of the presence of hepatitis B e antigen on prognosis after liver resection for hepatocellular carcinoma in patients with chronic hepatitis B. World J Surg 2002 0.80
35 Successful surgical control for hepatocellular carcinoma disseminated to the peritoneum: a case report. Hepatogastroenterology 2002 0.80
36 Convenience of a tape-guiding technique in different types of hepatectomy. Hepatogastroenterology 2008 0.80
37 Splenic metastasis of hepatocellular carcinoma. Osaka City Med J 2006 0.79
38 Immunohistochemical demonstration of c-Kit protooncogene product in gallbladder cancer. J Hepatobiliary Pancreat Surg 2006 0.79
39 Postoperative survival in intrahepatic cholangiocarcinoma showing intraductal growth. Hepatogastroenterology 2005 0.79
40 Influence of interferon therapy on outcome after surgery for hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2006 0.79
41 Power Doppler ultrasonographic diagnosis of small hepatocellular carcinomas. Dig Surg 2002 0.78
42 Resectable Pleomorphic Giant Cell Carcinoma of the Pancreas. Int J Gastrointest Cancer 2001 0.78
43 Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B. Surg Today 2005 0.78
44 Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg 2004 0.78
45 Alcohol abuse as an etiologic factor for hepatocellular carcinoma in Japan. Hepatol Res 2005 0.78
46 Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy. Surg Today 2007 0.78
47 Resection of needle-tract implantation after percutaneous puncture for hepatocellular carcinoma. J Gastroenterol 2004 0.77
48 Clinicopathologic characteristics of small intrahepatic cholangiocarcinomas of mass-forming type. Hepatol Res 2004 0.77
49 A long-term survival case underwent repeated hepatic arterial infusion chemotherapy with portal branch ligation and wrapping of the liver using sheets for hepatocellular carcinoma. Hepatogastroenterology 2002 0.77
50 Clinicopathologic analysis of risk factors for distant metastasis of hepatocellular carcinoma. Hepatol Res 2004 0.77
51 Bowel injury associated with liver surgery for hepatocellular carcinoma. Hepatogastroenterology 2006 0.77
52 Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers. Hepatogastroenterology 2002 0.77
53 Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma. Hepatogastroenterology 2002 0.77
54 Limitation of portal vein embolization for extension of hepatectomy indication in patients with hepatocellular carcinoma. Hepatogastroenterology 2004 0.77
55 Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma. Hepatogastroenterology 2003 0.77
56 Expression of bile duct-type cytokeratin in hepatocellular carcinoma in patients with hepatitis C virus and prior hepatitis B virus infection. Cancer Lett 2002 0.77
57 Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2002 0.77
58 A mixed hepatocellular carcinoma and cholangiocarcinoma: dual expression of biliary-type cytokeratin and hepatocyte specific marker. Hepatogastroenterology 2004 0.76
59 Prognostic factors in patients with carcinoma of the papilla of Vater. Hepatogastroenterology 2002 0.76
60 Multifocal hepatocellular carcinoma in patients undergoing living-related liver transplantation. Hepatogastroenterology 2003 0.76
61 Prognostic effects of causative virus in hepatocellular carcinoma according to the Japan integrated staging (JIS) score. J Gastroenterol 2005 0.76
62 Histopathological characterization of hepatocellular carcinomas which are undetected by dynamic computed tomography. Comp Hepatol 2004 0.75
63 Correction: Long-Term Benefits of Smoking Cessation on Gastroesophageal Reflux Disease and Health-Related Quality of Life. PLoS One 2016 0.75
64 Type IV collagen 7s domain as a predictor of poor efficacy of portal vein embolization before major hepatectomy. Surg Today 2005 0.75
65 Effects of marker for hepatic fibrosis and viral status on recurrence after resection of hepatitis B virus-related hepatocellular carcinoma. Hepatogastroenterology 2003 0.75
66 Polyamine metabolism and recurrence after resection for hepatocellular carcinoma. Hepatogastroenterology 2004 0.75
67 Two cases of intrahepatic cholangiocarcinoma detected after interferon therapy for chronic hepatitis C. Hepatogastroenterology 2005 0.75
68 Usefulness of biodegradable absorbable rib connecting pins in thoracoabdominal hepatectomy. Hepatogastroenterology 2003 0.75
69 Impact of mediastinal lymph node dissection on octogenarians with non-small cell lung cancer. Jpn J Thorac Cardiovasc Surg 2006 0.75
70 [Hepatic failure after liver resection in patients with cirrhosis]. Nihon Geka Gakkai Zasshi 2004 0.75
71 Risk factors for intractable pleural effusion after liver resection. Osaka City Med J 2004 0.75
72 Expression of bile duct-type cytokeratin in noncancerous hepatocytes in patients with hepatitis B virus-related hepatocellular carcinoma. Hepatogastroenterology 2003 0.75
73 [A case of a small intrahepatic cholangiocarcinoma treated with microwave coagulation therapy]. Nihon Shokakibyo Gakkai Zasshi 2005 0.75
74 Resection of hepatocellular carcinoma arising from primary biliary cirrhosis. J Gastroenterol 2004 0.75
75 Intrahepatic cystadenocarcinoma with pleural dissemination: a case report. Osaka City Med J 2003 0.75
76 Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma. Surg Today 2004 0.75
77 Pseudoaneurysm of the dorsal pancreatic artery with obstruction of the celiac axis after pancreatoduodenectomy: report of a case. Surg Today 2005 0.75
78 Curative resection of a huge bile duct cancer without pancreatoduodenectomy. Hepatogastroenterology 2004 0.75
79 Hepatocellular carcinoma fed by an aberrant posterior right hepatic artery. Hepatogastroenterology 2003 0.75
80 [A case of unresectable gastric cancer complicated by a serious hepatic disorder and Virchow lymph node metastasis in which FP therapy and TS-1 administration were effective]. Gan To Kagaku Ryoho 2002 0.75
81 Vascular Functional and Morphological Alterations in Smokers during Varenicline Therapy. Osaka City Med J 2015 0.75
82 Serum concentration of type IV collagen 7S domain as a marker for increased risk of recurrence after liver resection for hepatocellular carcinoma. Dig Surg 2003 0.75
83 Living-related liver transplantation in a patient with end-stage hepatolithiasis and a biliary-bronchial fistula. Hepatogastroenterology 2004 0.75
84 Portal thrombosis due to intrahepatic cholangiocarcinoma following successful treatment for hepatocellular carcinoma. Hepatogastroenterology 2003 0.75
85 Laparoscopic splenectomy for variceal bleeding with non-cirrhotic portal vein thrombosis: a case report. Hepatogastroenterology 2003 0.75
86 Percutaneous management of bile duct injuries after cholecystectomy. Hepatogastroenterology 2002 0.75